Published in MD Week, December 28th, 2007
"Primary outcomes were intraocular pressure (IOP) reduction and patient satisfaction. Adverse events and doctor satisfaction were secondary outcomes. Most patients were aged over 50, with 82% white, and nearly 90% had open-angle glaucoma. Combigan was used either as a replacement of, or an addition to, the patients' existing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week